Search results for "Juva"

showing 9 items of 739 documents

COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adju…

2014

5 Office-based Professional Association Gynecologic Oncologists e.V. in Germany (BNGO e.V.), Berlin; 6 Background: This prospective study evaluated the relationship between arthralgia and compliance during the first year of adjuvant anastrozole therapy in postmenopausal women with hormone receptor-positive early breast cancer. Patients and methods: COMPliance and Arthralgia in Clinical Therapy (COMPACT) was an open-label, multicenter, noninterventional study conducted in Germany. Patients had started adjuvant anastrozole 3-6 months before the study start. The primary end points were arthralgia, compliance, and the relationship between compliance and arthralgia, assessed at specific time poi…

musculoskeletal diseasesmedicine.medical_specialtyAntineoplastic Agents Hormonalmedicine.medical_treatmentSpecific timeAnastrozoleBreast NeoplasmsAnastrozoleMedication AdherenceBreast cancerInternal medicineNitrilesmedicineHumansProspective Studiesskin and connective tissue diseasesProspective cohort studyAgedbusiness.industryDrug SubstitutionIncidence (epidemiology)IncidenceHematologyMiddle AgedTriazolesmedicine.diseaseArthralgiaSurgeryCompliance (physiology)Clinical therapyTreatment OutcomeOncologyChemotherapy AdjuvantFemalebusinessAdjuvantmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Chemopreventive and Anticancer Role of Resveratrol against Oral Squamous Cell Carcinoma

2023

Oral squamous cell carcinoma (OSCC) is one of the most prevailing and aggressive head and neck cancers, featuring high morbidity and mortality. The available conventional treatments suffer from several adverse effects and are often inefficient in terms of their survival rates. Thus, seeking novel therapeutic agents and adjuvants is of the utmost importance for modern society. Natural polyphenolic compounds have recently emerged as promising chemopreventive and anticancer agents. Specifically, the natural compound resveratrol (RSV) has recently gained momentum for this purpose. RSV is useful for treating OSCC due to its antiproliferative, antimetastatic, and proapoptotic effects. Additionall…

natural compoundoral squamous cell carcinomaantimetastaticadjuvantSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSettore MED/28 - Malattie OdontostomatologichepolydatinPharmaceutical Sciencechemopreventionresveratrolanticancerpolyphenols
researchProduct

Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy

2022

In a scenario where eco-sustainability and a reduction in chemotherapeutic drug waste are certainly a prerogative to safeguard the biosphere, the use of natural products (NPs) represents an alternative therapeutic approach to counteract cancer diseases. The presence of a heterogeneous cancer stem cell (CSC) population within a tumor bulk is related to disease recurrence and therapy resistance. For this reason, CSC targeting presents a promising strategy for hampering cancer recurrence. Increasing evidence shows that NPs can inhibit crucial signaling pathways involved in the maintenance of CSC stemness and sensitize CSCs to standard chemotherapeutic treatments. Moreover, their limited toxici…

natural productcancer stem cellpolyphenoldrug resistanceSettore MED/50 - Scienze Tecniche Mediche ApplicateflavonoidGeneral MedicineSettore MED/46 - Scienze Tecniche Di Medicina Di Laboratorioalkaloidadjuvant treatmentsJournal of Clinical Medicine
researchProduct

Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a m…

2023

BackgroundIn triple negative breast cancer patients treated with neoadjuvant chemotherapy, residual disease at surgery is the most relevant unfavorable prognostic factor. Current guidelines consider the use of adjuvant capecitabine, based on the results of the randomized CREATE-X study, carried out in Asian patients and including a small subset of triple negative tumors. Thus far, evidence on Caucasian patients is limited, and no real-world data are available.MethodsWe carried out a multicenter, observational study, involving 44 oncologic centres. Triple negative breast cancer patients with residual disease, treated with adjuvant capecitabine from January 2017 through June 2021, were recrui…

neoadjuvant treatmentCancer ResearchOncologytriple negative breast canceradjuvant capecitabineresidual tumorsresidual tumortreatment discontinuationFrontiers in Oncology
researchProduct

Efficacy of one-year maintenance in early adjuvant chemotherapy for intermediate risk non-muscle-invasive bladder cancer. Preliminary results of a ra…

2008

Introduction and Objective: The clinical value of early intravesical adjuvant chemotherapy after TUR of intermediate risk non-muscle-invasive bladder cancer (NMI TCCB) is well established. On the other hand, the optimal schedule regimen and the role of maintenance are still debated. The aim of the present study was to evaluate the effectiveness of one-year maintenance schedule in patients submitted to TUR plus adjuvant early intravesical chemotherapy. Methods: Between May 2002 and August 2003, 577 patients, were recruited. All patients underwent TUR and early (within 6 hours) intravesical chemotherapy with epirubicin at the dose of 80 mg diluted in 60 ml of saline solution. When histology w…

non-muscle-invasive bladder cancer adjuvant chemotherapy
researchProduct

Adherence to oral hormonal anticancer agents in breast cancer.

2022

There is an increasing trend towards using oral antitumoral agents in oncological patients. Compared to parenteral therapy, oral treatment offers convenience for both the patient and the healthcare system, with similar efficacy. However, the benefit deriving from oral drugs will be obtained only if patients adhere strictly to the treatment. Medical oncologists must therefore seek to optimize patient adherence. Breast cancer patients, particularly, are often treated with oral hormonal anticancer agents. In this review, we summarized evidence about adherence of breast cancer patients to oral hormonal anticancer agents and the consequences of poor compliance, the barriers to oral treatment an…

oral antitumoral agentsCancer Researchbreast cancerOncologyAdherenceadjuvant endocrine therapyGeneral MedicineTumori
researchProduct

Gremošanas sistēmas akūtās blaknes onkoloģiskiem pacientiem, saņemot neoadjuvanto mērķterapiju

2020

Bakalaura darba tēma ir “Gremošanas sistēmas akūtas blaknes onkoloģiskiem pacientiem, saņemot neoadjuvantu terapiju”. Bakalaura darba mērķis ir novērtēt akūtas gremošanas sistēmas blaknes onkoloģiskiem pacientiem saņemot tikai staru terapiju vai kombinētu neoadjuvantu mēķterapiju ar taisnās zarnas un tūpļa kanāla audzējiem, balstoties uz RTOG skalas. Bakalaura darbs sastāv no teorijas daļas un pētījuma daļas. Darba apjoms ir 43 lpp. Bakalaura darbā izvirzīta hipotēze ir agrīnas staru terapijas blaknes attīstīsies agrāk un būs smagākas pacientiem, kuri vienlaicīgi saņem staru terapiju un ķīmijterapiju. Pētījuma daļā tika pielietota kvalitatīvi prospektīva pētījuma metode, ar kuras palīdzību …

pacientsonkoloģijablaknesneoadjuvanta terapijagremošanas sistēmaMedicīna
researchProduct

La Reggia di Venaria Reale in Italy and Palacio Real de Aranjuez in Spain: history, restoration and significance, comparative study between Two Royal…

2017

La investigación relaciona dos sitios reales, La Reggia di Venaria Reale en Italia y el Palacio Real de Aranjuez en España, confrontando su desarrollo histórico y arquitectónico, las obras de restauración llevadas a cabo, los criterios para su inclusión en la Lista de Patrimonio Mundial y su uso hoy en día como museos. El estudio comparativo muestra cómo ambos palacios se usaban inicialmente como residencias de caza en lugares con abundancia de agua y pesca. Además, los dos están ubicados cerca de las capitales políticas de su tiempo; esto es, Turín y Madrid. El hecho que el mismo arquitecto – Filippo Juvarra estuviera presente en ambas residencias reales contribuye a las similitudes, y en …

restorationgiacomo bonaviajuan de villanuevaarquitecturavenaria realepalacio real de madridreggia di venaria realescuderiapatrimonio mundialfrancisco sabatinibenedetto alfierimuseospalacio real de aranjuezpalacio real de la granja de san ildefonsogalleria grandecarlo randonipatrimonio:HISTORIA [UNESCO]santiago bonaviamichelangelo garoveUNESCO::HISTORIAitaliasitios realespatrimonio de la humanidadaranjuezgiuseppe battista piacenzafilippo juvarrajuan bautista de toledoamedeo di castellamonteworld heritage sitescitronierajuan de herrera
researchProduct

Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled…

2013

Obesity is an unfavorable prognostic factor in breast cancer (BC) patients regardless of menopausal status and treatment received. However, the association between obesity and survival outcome by pathological subtype requires further clarification. METHODS: We performed a retrospective analysis including 5,683 operable BC patients enrolled in four randomized clinical trials (GEICAM/9906, GEICAM/9805, GEICAM/2003-02, and BCIRG 001) evaluating anthracyclines and taxanes as adjuvant treatments. Our primary aim was to assess the prognostic effect of body mass index (BMI) on disease recurrence, breast cancer mortality (BCM), and overall mortality (OM). A secondary aim was to detect differences o…

Índice de Masa CorporalOncologyReceptor ErbB-2medicine.medical_treatmentObesidad:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Survival Analysis [Medical Subject Headings]Supervivencia sin EnfermedadBody Mass IndexAntineoplastic Combined Chemotherapy ProtocolsMedicineAnthracyclinesYoung adultMedicine(all)Hazard ratioNeoplasias de la MamaPronósticoFemeninoMiddle AgedPrognosisChemotherapy regimenTreatment OutcomeFemaleTaxoidsMastectomyResearch ArticleAdultmedicine.medical_specialtyAnálisis de Supervivencia:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Physical Examination::Body Constitution::Body Weights and Measures::Body Mass Index [Medical Subject Headings]Breast NeoplasmsDisease-Free SurvivalYoung AdultBreast cancerInternal medicineAdjuvant therapyHumansObesity:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Disease-Free Survival [Medical Subject Headings]:Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms [Medical Subject Headings]AgedGynecologyDose-Response Relationship Drugbusiness.industry:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [Medical Subject Headings]Retrospective cohort studyAntineoplásicosmedicine.disease:Diseases::Nutritional and Metabolic Diseases::Nutrition Disorders::Overnutrition::Obesity [Medical Subject Headings]:Check Tags::Female [Medical Subject Headings]Multivariate Analysis:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis [Medical Subject Headings]Neoplasm Recurrence LocalbusinessBody mass index
researchProduct